Back
Lululemon Athletica Vs. CRISPR Therapeutics AG Industry Stock Comparison
Sell
48
LULU
Lululemon Athletica
Last Price:
$337.46
Seasonality Move:
19.38%
Sell
6
CRSP
CRISPR Therapeutics AG
Last Price:
$40.90
Seasonality Move:
13.67%
Sell
48
Lululemon Athletica (LULU)
is a Sell
Is Lululemon Athletica a Buy, Sell or Hold?
-
The current Lululemon Athletica [LULU] share price is $337.35. The Score for LULU is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
LULU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
6
CRISPR Therapeutics AG (CRSP)
is a Sell
Is CRISPR Therapeutics AG a Buy, Sell or Hold?
-
The current CRISPR Therapeutics AG [CRSP] share price is $40.89. The Score for CRSP is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
CRSP is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
LULU Stock Price Chart
What is Lululemon Athletica's stock price today?
-
The Lululemon Athletica share price today is $337.35Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LULU is experiencing selling pressure, which indicates risk of future bearish movement.
CRSP Stock Price Chart
What is CRISPR Therapeutics AG's stock price today?
-
The CRISPR Therapeutics AG share price today is $40.89Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRSP is experiencing selling pressure, which indicates risk of future bearish movement.
LULU Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -12.45 | Sell |
Relative Strength Index (14 RSI): | 46.11 | Sell |
Chaikin Money Flow: | -1149851 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (323.36 - 363.22) | Sell |
Bollinger Bands (100): | (322.99 - 394.63) | Sell |
CRSP Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.23 | Buy |
Relative Strength Index (14 RSI): | 43.54 | Sell |
Chaikin Money Flow: | -1431436 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.96 - 47.82) | Sell |
Bollinger Bands (100): | (40.53 - 49.17) | Sell |
LULU Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 326.27 | Buy |
20-day SMA: | 337.56 | Sell |
50-day SMA: | 370.29 | Sell |
200-day SMA: | 317.77 | Buy |
8-day EMA: | 329.91 | Buy |
20-day EMA: | 338.99 | Sell |
50-day EMA: | 354.59 | Sell |
200-day EMA: | 345.55 | Sell |
CRSP Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 41.72 | Sell |
20-day SMA: | 42.82 | Sell |
50-day SMA: | 42.77 | Sell |
200-day SMA: | 48.27 | Sell |
8-day EMA: | 26.3 | Buy |
20-day EMA: | 13.68 | Buy |
50-day EMA: | 6.13 | Buy |
200-day EMA: | 1.63 | Buy |
Lululemon Athletica Earnings Growth & LULU Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.40 per share, an increase next quarter of $2.95 per share, an increase this year of $1.92 per share, and an increase next year of $1.02 per share.
CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.16 per share, an increase next quarter of $0.06 per share, an increase this year of $0.22 per share, and an increase next year of $0.93 per share.
Lululemon Athletica Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
CRISPR Therapeutics AG Technical Analysis
Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |